seed
Stage
About
Libera Bio develops a proprietary nanotechnology platform to deliver biologics, such as antibodies, intracellularly to target previously undruggable cancer targets, focusing on therapies for oncology.
Explore Libera Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.